United Therapeutics
UTHR
#1032
Rank
C$30.54 B
Marketcap
C$675.43
Share price
0.65%
Change (1 day)
28.19%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2025 (TTM): C$40.10

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is C$39.78. In 2024 the company made an earnings per share (EPS) of C$36.90 an increase over its 2023 EPS that were of C$29.38.

EPS history for United Therapeutics from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$40.108.66%
2024C$36.9025.59%
2023C$29.3831.54%
2022C$22.3451.18%
2021C$14.78-9.1%
2020C$16.25-581.4%
2019C-$3.38-117.79%
2018C$18.9842.11%
2017C$13.35-40.93%
2016C$22.6013.45%
2015C$19.92104.29%
2014C$9.75100.29%
2013C$4.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
C$28.63-28.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$9.10-77.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.88-97.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
C$2.40-93.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$0.92-102.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C-$8.78-122.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$5.02-87.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
C$9.29-76.64%๐Ÿ‡บ๐Ÿ‡ธ USA